HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 10, September 2017 – Cardiovascular diseases       » Test strips for cancer detection get upgraded with nanoparticle bling       » Smart nano-pesticide to combat soil and water contamination       » China plans to launch "brain project" by year end       » UNAIDS encourages Chinese to produce drugs for Africa       » Korea-Singapore Healthcare Incubator to support Korean firms in Singapore and Southeast Asia       » Nanomaterial wrap for improved tissue imaging      

INSIDE INDUSTRY

Bayer and NUS Enterprise Announce Winners of Grants4Apps® Singapore Open Innovation Challenge
  • 3 winning teams from Singapore and Thailand awarded for their innovative health-tech solutions to overcome medication adherence barriers in elderly people with chronic diseases.
  • nnovative concepts address a significant health challenge as patient adherence to long-term therapies is only 50% [1].
  • Bayer and NUS Enterprise to support the winners in advancing their project ideas with an award of S$10,000 each and access to mentorships, incubator space, and global and regional networks.

SINGAPORE – Bayer and NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), announced (May 3) three winners from 80 applications of the inaugural round of Grants4Apps® Singapore, a web-based crowdsourcing initiative that calls for innovative health-tech solutions to improve medication adherence in elderly people with chronic diseases across Asia Pacific. The three teams of winners are from Singapore and Thailand.

Grants4Apps® Singapore is part of Bayer’s global Grants4Apps® program that supports innovators for their health-tech ideas which contribute to improvements in health outcomes or pharmaceutical processes. The first round of the challenge was jointly launched by Bayer and NUS Enterprise on 1st December 2016 at the Transforming Aging with Health Innovation Forum, officiated by Dr Amy Khor, Senior Minister of State for Ministry of Health, Singapore. The crowdsourcing initiative closed on 31st March 2017 with a total of 80 applications from countries including Singapore, Thailand, India, Australia, Taiwan, S. Korea, and the Philippines. While the call for ideas focused mainly on the Asia Pacific region, Grants4Apps® Singapore also received applications from countries outside the region such as the United States of America (USA).

“Our Grants4Apps® program fosters digital and technological innovations in healthcare globally. We are impressed by the wealth of ideas and the high quality of our finalists from this regional chapter of our program which focuses on finding solutions to improve medication adherence in our rapidly aging population,” said Kemal Malik, Member of the Board of Management, responsible for Innovation at Bayer, as he gave out the awards to the three winning teams. “Some of these concepts have the potential to benefit patients, doctors and consumers, revolutionlizing healthcare delivery and improving treatment results. We are delighted to support the winners in advancing their innovative ideas.”

After an intensive evaluation of the applications, six finalist teams were selected for coaching and mentorship followed by a final round of pitching and an awards ceremony, held today at Innovfest Unbound, an anchor event of Singapore’s Smart Nation Innovations week 2017 featuring Asia’ most innovative developments.

The winners of Grants4Apps® Singapore are:

  • EyeDEA, Singapore
  • Glycoleap by Holmusk, Singapore
  • PillPocket, Thailand

A panel of distinguished judges from Bayer, NUS Enterprise and the industry evaluated the applications based on originality and practicality; the teams should be able to develop their proposed innovative concepts into minimum viable products in about six months to improve medication adherence in elderly people with chronic diseases. There were no restrictions on platforms, operating systems and/or technologies.

“We are honoured to partner with Bayer on the Singapore edition of Grants4Apps® focusing on medication adherence. We were impressed with the quality of submissions received, and we believe the ideas and innovations presented today will help create lasting social impact amongst the senior community in Singapore, the region and beyond,” said Lily Chan, CEO of NUS Entreprise, who was also part of the judging panel for Grants4Apps® Singapore.

Each winning team will receive an award of S$10,000 and access to mentorships and a global and regional network from Bayer, NUS and other industry partners to refine and scale their project. The teams will also be eligible for incubator support from NUS Enterprise as well as access to the Modern Aging Singapore business accelerator program, organized by ACCESS Health international and NUS Enterprise. They may also be admitted to the global Grants4Apps® program and the Grants4Apps® Accelerator and stand a chance to receive additional financial support, mentorships by Bayer managers and an international network of external entrepreneurs as well as co-working space at the global headquarters of Bayer Pharmaceuticals division in Berlin, Germany.

Other finalists of Grants4Apps® Singapore are:
  • Pill-E, Singapore: A smart pill box integrated with an intuitive application that helps caregivers and patients to simplify and adhere to complex medication with ease. The intelligent application logs dosing pattern and adherence which can be shared with the doctor for assessment. Additional in-built mechanisms also prevent medication misuse. While differentiating from a normal pill box with its “smart” functions, Pill-e also offers a more affordable and convenient option to a pill dispenser.
  • Onward Health, India: A software which helps postoperative patients follow their discharge instructions and doctor’s advice, including physiotherapy, medication adherence and other vital parameters needed to be tracked. It helps patients stay connected to their postoperative care network through a simple communication platform enabling hospitals and doctors to keep track of their patients’ health after discharge. A dashboard also provides a view of the patient’s compliance as well as real-time health status.
  • Intemed by SMJ Engineering, USA: A device integrated with a smartphone to provide digital medication management by healthcare professionals to combat medication nonadherence. A smart cartridge pill container with an embedded memory chip can be programmed by a pharmacist with an encrypted medication ID, digital prescription, reordering data and all other pertinent medication information. The catridge is then inserted into the device by the patient and the app automatically identifies the medications, programmes schedules, re-orders, notifies the patient about medication intake and dispenses the medications.

About Grants4Apps and Grants4Apps Accelerator

Grants4Apps® is a web-based crowdsourcing initiative, launched in 2013. It provides financial support to developers and startups for their software, hardware and technology projects which contribute to improve health outcomes or pharmaceutical processes. The crowdsourcing program was expanded with the Accelerator as a new model of open innovation in the digital health field in 2014.

The Grants4Apps® Accelerator offers dedicated office space for up to 5 digital health startups with concepts for innovative technology solutions to healthcare problems at the headquarters of the company’s pharmaceuticals division in Berlin to support them in further advancing their projects and business models. Each startup receives 50,000 Euro as financial support and can stay in the Grants4Apps® Accelerator premises for about 100 days. During that time, Bayer offers experienced managers as coaches to the startups, in addition to intensive mentoring by external entrepreneurs. Thereby, the Accelerator creates an ideal environment in which to advance cutting-edge technologies in healthcare and underlines Bayer’s engagement in collaboration with young entrepreneurs.

Bayer has also launched local chapters of Grants4Apps® in Barcelona, Shanghai, Tokyo, Italy, Moscow, Toronto, Seoul and Singapore, with each chapter focusing on local and/or regional adaptations of digital innovation in healthcare.

Reference:

  1. Kathleen Holloway, Liset van Dijk 2011, The World Medicines Situation 2011: Rational Use Of Medicines, World Health Organisation, Accessed 15 November 2016, http://www.who.int/medicines/areas/policy/world_medicines_situation/WMS_ch14_wRational.pdf (last accessed: November 29, 2016)
Source: Bayer

Click here for the complete issue.

NEWS CRUNCH  
news Medical technology experts to address the impact of innovation in shaping patient outcomes across Asia Pacific
news China biotech's 'coming out party' masks long road ahead
news SingHealth, Duke NUS and GSK to conduct large-scale big data study on asthma and COPD in Singapore
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Infectious Diseases
October:
A change of heart — Cardiovascular diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy